Towards targeted removal of
treatment-resistant glioma stem cells
Celluminova specializes in developing innovative technologies designed to detect cancer stem cells. Our ambition is to make these highly invasive and treatment-resistant cells visible, opening new possibilities for how they can be addressed. Our initial indication is high-grade gliomas, including glioblastoma.
GlioStem® is a new product designed for near-instant detection of glioma stem cells.
It is based on polymer technology and defines a new generation of biomarkers.
